文献速递心脑血管急症重症综合管理与镇静镇痛

急诊科集束化治疗对老年急性心衰患者30天离院存活天数的影响:ELISABETH随机临床试验

Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
PubMed 文献 · JAMA · 2020-01-01
一句话结论在≥75岁急诊急性心衰患者中,早期指南推荐集束化治疗(静脉硝酸酯推注、处理诱因、中等剂量静脉利尿剂)较常规治疗未显著改善30天存活且离院天数。

ELISABETH为法国15个急诊科开展的阶梯楔形整群随机试验,纳入503例≥75岁急诊急性心衰患者,干预组接受早期静脉硝酸酯推注、处理诱因及中等剂量静脉利尿剂,对照组由急诊医师自主决策。主要终点30天存活且离院天数两组中位数均为19天(调整差-1.9,95%CI -6.6至2.8;调整比0.88,95%CI 0.64-1.21),无统计学显著差异。30天全因死亡、心血管死亡、非计划再入院、住院时长及肾功能损害均无显著差异。该集束化治疗未改善老年急性心衰患者短期预后。

要点

  • 研究纳入503例≥75岁(中位87岁,59%女性)急诊急性心衰患者,干预组200例、对照组303例,502例纳入分析。
  • 干预组前4小时静脉硝酸酯中位剂量27.0 mg(IQR 9-54),对照组4.0 mg(IQR 2.0-6.0),调整差23.8 mg(95%CI 13.5-34.1)。
  • 干预组诱因处理率58.8% vs 对照组31.9%(调整差31.1%,95%CI 14.3%-47.9%)。
  • 主要终点30天存活且离院天数两组中位数均为19天(IQR 0-24),调整差-1.9天(95%CI -6.6至2.8),无显著差异。
  • 30天全因死亡8.0% vs 9.7%(调整差4.1%,95%CI -17.2%至25.3%),心血管死亡、非计划再入院、住院时长及肾功能损害均无显著差异。

适用人群与场景

  • 法国15个急诊科中≥75岁、急诊诊断为急性心衰的患者,中位年龄87岁,59%为女性。

诊断标准与关键阈值

  • 原文未提及急性心衰的具体诊断标准或评分界值。

处置流程与药物剂量

  • 干预组:早期静脉硝酸酯推注,前4小时中位总剂量27.0 mg(IQR 9-54)。
  • 干预组:处理诱因,包括急性冠脉综合征、感染或心房颤动(原文举例),干预组处理率58.8%。
  • 干预组:中等剂量静脉利尿剂(原文未给出具体剂量、单位和频次)。
  • 对照组:由治疗急诊医师自主决策,前4小时静脉硝酸酯中位总剂量4.0 mg(IQR 2.0-6.0)。
  • 原文未给出各药物的具体给药频次、疗程目标值或滴定方案。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:阶梯楔形整群随机试验,法国15个急诊科,纳入503例≥75岁急诊急性心衰患者(干预组200例,对照组303例),502例分析。
  • 干预:早期静脉硝酸酯推注+处理诱因(急性冠脉综合征、感染或心房颤动)+中等剂量静脉利尿剂;对照:急诊医师自主决策。
  • 主要终点30天存活且离院天数:两组中位数均为19天(IQR 0-24),调整差-1.9天(95%CI -6.6至2.8),调整比0.88(95%CI 0.64-1.21),无统计学显著差异。
  • 30天全因死亡:8.0% vs 9.7%,调整差4.1%(95%CI -17.2%至25.3%);心血管死亡:5.0% vs 7.4%,调整差2.1%(95%CI -15.5%至19.8%)。
  • 非计划再入院:14.3% vs 15.7%,调整差-1.3%(95%CI -26.3%至23.7%);住院时长中位数两组均为8天,调整差2.5天(95%CI -0.9至5.8);肾功能损害两组均为1%。

证据类型、等级与局限

  • 证据类型:阶梯楔形整群随机临床试验(RCT),注册号NCT03683212。
  • 局限:原文未明确列出局限;设计上为整群随机、开放标签(对照组由医师自主决策),样本量503例,仅法国15个急诊科。

对床旁实践的改变

  • 对于≥75岁急诊急性心衰患者,按指南推荐实施早期静脉硝酸酯推注、诱因处理及中等剂量静脉利尿剂的集束化治疗,未显示可改善30天存活且离院天数。
  • 该集束化治疗未显著改变30天全因死亡、心血管死亡、非计划再入院、住院时长或肾功能损害。
  • 原文未提及该集束化治疗的适用或不适用人群,也未提及常见陷阱。

指南或共识出处

  • 原文未提及具体指南或共识名称;原文提及临床指南对急诊急性心衰早期管理的证据水平仅为中等。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Clinical guidelines for the early management of acute heart failure in the emergency department (ED) setting are based on only moderate levels of evidence, with subsequent low adherence to these guidelines.

OBJECTIVE: To test the effect of an early guideline-recommended care bundle on short-term prognosis in older patients with acute heart failure in the ED.

DESIGN, SETTING, AND PARTICIPANTS: Stepped-wedge cluster randomized trial in 15 EDs in France of 503 patients 75 years and older with a diagnosis of acute heart failure in the ED from December 2018 to September 2019 and followed up for 30 days until October 2019.

INTERVENTIONS: A care bundle that included early intravenous nitrate boluses; management of precipitating factors, such as acute coronary syndrome, infection, or atrial fibrillation; and moderate dose of intravenous diuretics (n = 200). In the control group, patient care was left to the discretion of the treating emergency physician (n = 303). Each center was randomized to the order in which they switched to the "intervention period." After the initial 4-week control period for all centers, 1 center entered in the intervention period every 2 weeks.

MAIN OUTCOMES AND MEASURES: The primary end point was the number of days alive and out of hospital at 30 days. Secondary outcomes included 30-day all-cause mortality, 30-day cardiovascular mortality, unscheduled readmission, length of hospital stay, and kidney impairment.

RESULTS: Among 503 patients who were randomized (median age, 87 years; 298 [59%] women), 502 were analyzed. In the intervention group, patients received a median (interquartile range) of 27.0 (9-54) mg of intravenous nitrates in the first 4 hours vs 4.0 (2.0-6.0) mg in the control group (adjusted difference, 23.8 [95% CI, 13.5-34.1]). There was a significantly higher percentage of patients in the intervention group treated for their precipitating factors than in the control group (58.8% vs 31.9%; adjusted difference, 31.1% [95% CI, 14.3%-47.9%]). There was no statistically significant difference in the primary end point of the number of days alive and out of hospital at 30 days (median [interquartile range], 19 [0- 24] d in both groups; adjusted difference, -1.9 [95% CI, -6.6 to 2.8]; adjusted ratio, 0.88 [95% CI, 0.64-1.21]). At 30 days, there was no significant difference between the intervention and control groups in mortality (8.0% vs 9.7%; adjusted difference, 4.1% [95% CI, -17.2% to 25.3%]), cardiovascular mortality (5.0% vs 7.4%; adjusted difference, 2.1% [95% CI, -15.5% to 19.8%]), unscheduled readmission (14.3% vs 15.7%; adjusted difference, -1.3% [95% CI, -26.3% to 23.7%]), median length of hospital stay (8 d in both groups; adjusted difference, 2.5 [95% CI, -0.9 to 5.8]), and kidney impairment (1% in both groups).

CONCLUSIONS AND RELEVANCE: Among older patients with acute heart failure, use of a guideline-based comprehensive care bundle in the ED compared with usual care did not result in a statistically significant difference in the number of days alive and out of the hospital at 30 days. Further research is needed to identify effective treatments for acute heart failure in older patients.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03683212.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Freund Y, Cachanado M, Delannoy Q, et al. Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial. JAMA. 2020. PMID: 33201202. doi:10.1001/jama.2020.19378

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。